These observations are not limited to experimental models, as analysis of RNA sequencing (RNA-seq) data from two independent cohorts of BRAF-mutant melanoma patients treated with BRAFi revealed consistent upregulation of CD36 in early on-treatment melanoma biopsies when compared with the pretreatment biopsies [68]. Here, CD36 is linked to melanoma.